Title:
カルジオトロフィンおよびその使用
Document Type and Number:
Japanese Patent JP3906314
Kind Code:
B2
Abstract:
Isolated CHF, isolated DNA encoding cardiac hypertrophy factor (CHF), and recombinant or synthetic methods of preparing CHF are disclosed. These CHF molecules are shown to influence hypertrophic activity and neurological activity. Accordingly, these compounds or their antagonists may be used for treatment of heart failure, arrhythmic disorders, inotropic disorders, and neurological disorders.
More Like This:
JPH09512253 | A human bone stimulus factor |
JP4470077 | Mice deficient in neutrophil chemotaxis factor LECT2 gene function |
JPH10243789 | PROTEIN BONDING TO MEDICINE |
Inventors:
Baker, joffre
Chen, Kenneth
King, Kathleen
Penica, Diane
Wood william
Chen, Kenneth
King, Kathleen
Penica, Diane
Wood william
Application Number:
JP52767695A
Publication Date:
April 18, 2007
Filing Date:
April 06, 1995
Export Citation:
Assignee:
Genentech Incorporated
The Regents of the University of California
The Regents of the University of California
International Classes:
C07K14/52; G01N33/53; C07K16/24; C12N5/10; C12N15/02; C12N15/09; C12N15/19; C12P21/02; C12P21/08; C12Q1/02; C12Q1/68; G01N33/68; A61K38/00; C12R1/91
Other References:
Proc.Natl.Acad.Sci.USA,February 1995,Vol.92,p.1142-1146
Attorney, Agent or Firm:
Sonoda Yoshitaka
Kobayashi Yoshinori
Kobayashi Yoshinori
Previous Patent: 減圧式乾燥機及びそれを用いた木材の乾燥方法
Next Patent: METHOD AND DEVICE FOR GENERATING HORIZONTAL-DIRECTIONAL REFERENCE FORCE
Next Patent: METHOD AND DEVICE FOR GENERATING HORIZONTAL-DIRECTIONAL REFERENCE FORCE